Detalhes bibliográficos
Ano de defesa: |
2010 |
Autor(a) principal: |
Azevedo, Aparecida Marildes de
 |
Orientador(a): |
Bataglia, Walter
 |
Banca de defesa: |
Não Informado pela instituição |
Tipo de documento: |
Dissertação
|
Tipo de acesso: |
Acesso aberto |
Idioma: |
por |
Instituição de defesa: |
Universidade Presbiteriana Mackenzie
|
Programa de Pós-Graduação: |
Não Informado pela instituição
|
Departamento: |
Não Informado pela instituição
|
País: |
Não Informado pela instituição
|
Palavras-chave em Português: |
|
Palavras-chave em Inglês: |
|
Área do conhecimento CNPq: |
|
Link de acesso: |
http://dspace.mackenzie.br/handle/10899/23333
|
Resumo: |
In the Twentieth First Century, the modern biotechnology is detached as a relevant set of techniques for modifying organisms through genetic engineering, being able to collaborate to the scientific knowledge advance and the production of new drugs, vaccines and medicines. The interorganizational partnership has been pointed out by several researchers as an effective mean of knowledge transfer and assessing complementary assets in the value chain. The objective in this study is to understand the perception of managers about the influence of the technological environment on the interorganizational partnerships adoption in the biotechnology industry in Brazil, in the human health segment. The methodology involved case studies with two biotechnology companies and a pharmaceutical company with a partnership in the biotechnology industry, all of them located in the city of Sao Paulo, with a minimum of four years of experience. The analysis was conducted in two levels: interorganizational partnerships (description and motivations) and technological environment (appropriability, cumulativeness, opportunity and knowledge basis). The conclusion was that the environment presents high levels of appropriability, cumulativeness, opportunity and complexity of the knowledge basis. When the dimensions of the technological environment are considered high, there is strong motivation for interorganizational partnerships, leading companies to specialize and join with other experts to complete the tasks. The finding in this study suggest there is a high cumulativeness in the biotechnological environment in Brazil, providing the improvement of competences and the ability of companies to maintain the continuity of future innovations to cope with a competitive environment. The relevance of this study is the possibility to collaborate with managers to deep their knowledge about the characteristics of competitive and complex environment in which the Brazilian biotech industry for human health is embedded and interorganizational partnership. |